dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Reyes Garau, Diana |
dc.contributor.author | Ribeiro Lima, Marcelo |
dc.contributor.author | Roue, Gael |
dc.date.accessioned | 2020-07-31T12:45:56Z |
dc.date.available | 2020-07-31T12:45:56Z |
dc.date.issued | 2019-10-02 |
dc.identifier.citation | Reyes-Garau D, Ribeiro M, Roué G. Pharmacological targeting of BET bromodomain proteins in acute myeloid leukemia and malignant lymphomas: from molecular characterization to clinical applications. Cancers. 2019 Oct 2;11(10):1483. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/5128 |
dc.description | Bromodomini i domini extra terminal; BRD2; BRD4 |
dc.description.sponsorship | G.R. acknowledges supports from Fondo de Investigación Sanitaria PI15/00102 and PI18/01383, European Regional Development Fund (ERDF) “Una manera de hacer Europa”. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;11(10) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Hematologia oncològica |
dc.subject | Medicaments proteínics |
dc.subject | Farmacologia molecular |
dc.subject.mesh | Hematologic Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Protein Domains |
dc.subject.mesh | /drug effects |
dc.subject.mesh | Molecular Targeted Therapy |
dc.title | Pharmacological targeting of BET bromodomain proteins in acute myeloid leukemia and malignant lymphomas: from molecular characterization to clinical applications |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers11101483 |
dc.subject.decs | neoplasias hematológicas |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | dominios proteicos |
dc.subject.decs | /efectos de los fármacos |
dc.subject.decs | terapia molecular selectiva |
dc.relation.publishversion | https://www.mdpi.com/2072-6694/11/10/1483 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Reyes-Garau D, Roué G] Laboratori d’Hematologia Experimental, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Ribeiro M] Laboratori d’Hematologia Experimental, , Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Laboratory of Immunopharmacology and Molecular Biology, Sao Francisco University Medical School, Braganca Paulista, Brazil |
dc.identifier.pmid | 31581671 |
dc.identifier.wos | 000498826000080 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00102 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI18%2F01383 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |